Why is Aristo Bio-Tech falling/rising?

As of 29-Sep, Aristo Bio-Tech & Lifescience Ltd is experiencing a decline in its stock price, currently at 126.20, which reflects a decrease of 11.6 points or 8.42%. The stock has underperformed its sector by 8.19% today, and while it is higher than the 50-day, 100-day, and 200-day moving averages, it is lower than the 5-day and 20-day moving averages. Additionally, there has been a significant drop in investor participation, with delivery volume falling by 75% compared to the 5-day average. Over the past week, the stock has decreased by 8.42%, contrasting with a modest increase of 4.64% over the past month.
In the broader market context, the Sensex has declined by 2.25% over the past week, indicating that while Aristo Bio-Tech is underperforming, the overall market is also facing challenges. Year-to-date, the stock has dropped by 5.11%, while the Sensex has gained 4.19%, further highlighting the stock's struggles relative to the benchmark. The lack of available positive or negative dashboard data makes it difficult to pinpoint specific catalysts for the stock's recent movement, but the combination of declining investor interest and underperformance against both sector and benchmark suggests a challenging environment for Aristo Bio-Tech.